ent-16β,17-Dihydroxykauran-19-oic acid
Product Specifications
UNSPSC Description
ent-16β,17-Dihydroxykauran-19-oic acid is an anti-inflammatory agent, which can be isolated from Siegesbeckia pubescens herb. ent-16β,17-Dihydroxykauran-19-oic acid inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglia[1].
Target Antigen
Others
Type
Natural Products
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ent-16β-17-dihydroxykauran-19-oic-acid.html
Purity
98.0
Solubility
10 mM in DMSO
Smiles
C[C@]12[C@@]3([H])[C@]4(CC[C@]1([H])[C@@](C)(CCC2)C(O)=O)C[C@@](O)([C@@](CC3)([H])C4)CO
Molecular Weight
336.47
References & Citations
[1]Lee M, et al. ent-kaurane and ent-pimarane diterpenes from Siegesbeckia pubescens inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglia. Biol Pharm Bull. 2014;37(1):152-7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N3814/ent-16β-17-Dihydroxykauran-19-oic-acid-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N3814/ent-16β-17-Dihydroxykauran-19-oic-acid-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
3301-61-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
